These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15345185)

  • 41. Ethical considerations in testing workers for the -Glu69 marker of genetic susceptibility to chronic beryllium disease.
    Silver K; Sharp RR
    J Occup Environ Med; 2006 Apr; 48(4):434-43. PubMed ID: 16607200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity.
    Fontenot AP; Kotzin BL
    Tissue Antigens; 2003 Dec; 62(6):449-58. PubMed ID: 14617028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of genetic and exposure factors in the prevalence of berylliosis.
    Richeldi L; Kreiss K; Mroz MM; Zhen B; Tartoni P; Saltini C
    Am J Ind Med; 1997 Oct; 32(4):337-40. PubMed ID: 9258386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystal structure of HLA-DP2 and implications for chronic beryllium disease.
    Dai S; Murphy GA; Crawford F; Mack DG; Falta MT; Marrack P; Kappler JW; Fontenot AP
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7425-30. PubMed ID: 20356827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity.
    Rossman MD; Stubbs J; Lee CW; Argyris E; Magira E; Monos D
    Am J Respir Crit Care Med; 2002 Mar; 165(6):788-94. PubMed ID: 11897645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease.
    Falta MT; Pinilla C; Mack DG; Tinega AN; Crawford F; Giulianotti M; Santos R; Clayton GM; Wang Y; Zhang X; Maier LA; Marrack P; Kappler JW; Fontenot AP
    J Exp Med; 2013 Jul; 210(7):1403-18. PubMed ID: 23797096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory T cells modulate granulomatous inflammation in an HLA-DP2 transgenic murine model of beryllium-induced disease.
    Mack DG; Falta MT; McKee AS; Martin AK; Simonian PL; Crawford F; Gordon T; Mercer RR; Hoover MD; Marrack P; Kappler JW; Tuder RM; Fontenot AP
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8553-8. PubMed ID: 24912188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.
    Weston A; Ensey J; Kreiss K; Keshava C; McCanlies E
    Am J Ind Med; 2002 Jun; 41(6):457-65. PubMed ID: 12173370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between IL-1A single nucleotide polymorphisms and chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Yucesoy B; Mnatsakanova A; Slaven JE; Andrew M; Frye BL; Schuler CR; Kreiss K; Weston A
    J Occup Environ Med; 2010 Jul; 52(7):680-4. PubMed ID: 20595916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunologic Effects of Beryllium Exposure.
    Fontenot AP
    Ann Am Thorac Soc; 2018 Apr; 15(Suppl 2):S81-S85. PubMed ID: 29676647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
    Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS
    Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic markers in beryllium hypersensitivity.
    Stubbs J; Argyris E; Lee CW; Monos D; Rossman MD
    Chest; 1996 Mar; 109(3 Suppl):45S. PubMed ID: 8598150
    [No Abstract]   [Full Text] [Related]  

  • 53. Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention.
    Bartell SM; Ponce RA; Takaro TK; Zerbe RO; Omenn GS; Faustman EM
    Risk Anal; 2000 Feb; 20(1):87-99. PubMed ID: 10795342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metal-specific CD4+ T-cell responses induced by beryllium exposure in HLA-DP2 transgenic mice.
    Falta MT; Tinega AN; Mack DG; Bowerman NA; Crawford F; Kappler JW; Pinilla C; Fontenot AP
    Mucosal Immunol; 2016 Jan; 9(1):218-28. PubMed ID: 26129650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunology of chronic beryllium disease.
    Samuel G; Maier LA
    Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):126-34. PubMed ID: 18317020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease.
    Sawyer RT; Fontenot AP; Barnes TA; Parsons CE; Tooker BC; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Hagman J; Newman LS
    Am J Respir Cell Mol Biol; 2007 Feb; 36(2):191-200. PubMed ID: 16980557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic and exposure risks for chronic beryllium disease.
    Maier LA
    Clin Chest Med; 2002 Dec; 23(4):827-39. PubMed ID: 12516537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.
    Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Fingerlin TE; Sato H; Newman LS; Maier LA
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1680-8. PubMed ID: 21471109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.
    Snyder JA; Demchuk E; McCanlies EC; Schuler CR; Kreiss K; Andrew ME; Frye BL; Ensey JS; Stanton ML; Weston A
    J R Soc Interface; 2008 Jul; 5(24):749-58. PubMed ID: 17956852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.